<DOC>
	<DOCNO>NCT01297426</DOCNO>
	<brief_summary>Obesity respond high circulating level hormone leptin . This study aim find happens open new avenue treatment obesity .</brief_summary>
	<brief_title>Leptin Signaling Lean Obese Humans</brief_title>
	<detailed_description>Ex vivo vitro identification study leptin signal pathway commercially available cell line serum/ plasma sample discard tissue human .</detailed_description>
	<criteria>men woman age 18 65 BMI range 20 45 kg/m2 subject require special diet history illness obesity diabetes take medication know influence glucose metabolism subject history anaphylactic reaction hypersensitivity e. coli derive protein anesthetic agent woman breastfeed , pregnant want become pregnant subject bleed dyscrasia poor wound heal</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>